First Time Loading...

IRadimed Corp
NASDAQ:IRMD

Watchlist Manager
IRadimed Corp Logo
IRadimed Corp
NASDAQ:IRMD
Watchlist
Price: 40.36 USD -0.27% Market Closed
Updated: Apr 19, 2024

Intrinsic Value

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. [ Read More ]

The intrinsic value of one IRMD stock under the Base Case scenario is 28.32 USD. Compared to the current market price of 40.36 USD, IRadimed Corp is Overvalued by 30%.

Key Points:
IRMD Intrinsic Value
Base Case
28.32 USD
Overvaluation 30%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
IRadimed Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling IRMD stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
IRadimed Corp

Provide an overview of the primary business activities
of IRadimed Corp.

What unique competitive advantages
does IRadimed Corp hold over its rivals?

What risks and challenges
does IRadimed Corp face in the near future?

Has there been any significant insider trading activity
in IRadimed Corp recently?

Summarize the latest earnings call
of IRadimed Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for IRadimed Corp.

Provide P/S
for IRadimed Corp.

Provide P/E
for IRadimed Corp.

Provide P/OCF
for IRadimed Corp.

Provide P/FCFE
for IRadimed Corp.

Provide P/B
for IRadimed Corp.

Provide EV/S
for IRadimed Corp.

Provide EV/GP
for IRadimed Corp.

Provide EV/EBITDA
for IRadimed Corp.

Provide EV/EBIT
for IRadimed Corp.

Provide EV/OCF
for IRadimed Corp.

Provide EV/FCFF
for IRadimed Corp.

Provide EV/IC
for IRadimed Corp.

Show me price targets
for IRadimed Corp made by professional analysts.

What are the Revenue projections
for IRadimed Corp?

How accurate were the past Revenue estimates
for IRadimed Corp?

What are the Net Income projections
for IRadimed Corp?

How accurate were the past Net Income estimates
for IRadimed Corp?

What are the EPS projections
for IRadimed Corp?

How accurate were the past EPS estimates
for IRadimed Corp?

What are the EBIT projections
for IRadimed Corp?

How accurate were the past EBIT estimates
for IRadimed Corp?

Compare the revenue forecasts
for IRadimed Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of IRadimed Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of IRadimed Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of IRadimed Corp compared to its peers.

Compare the P/E ratios
of IRadimed Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing IRadimed Corp with its peers.

Analyze the financial leverage
of IRadimed Corp compared to its main competitors.

Show all profitability ratios
for IRadimed Corp.

Provide ROE
for IRadimed Corp.

Provide ROA
for IRadimed Corp.

Provide ROIC
for IRadimed Corp.

Provide ROCE
for IRadimed Corp.

Provide Gross Margin
for IRadimed Corp.

Provide Operating Margin
for IRadimed Corp.

Provide Net Margin
for IRadimed Corp.

Provide FCF Margin
for IRadimed Corp.

Show all solvency ratios
for IRadimed Corp.

Provide D/E Ratio
for IRadimed Corp.

Provide D/A Ratio
for IRadimed Corp.

Provide Interest Coverage Ratio
for IRadimed Corp.

Provide Altman Z-Score Ratio
for IRadimed Corp.

Provide Quick Ratio
for IRadimed Corp.

Provide Current Ratio
for IRadimed Corp.

Provide Cash Ratio
for IRadimed Corp.

What is the historical Revenue growth
over the last 5 years for IRadimed Corp?

What is the historical Net Income growth
over the last 5 years for IRadimed Corp?

What is the current Free Cash Flow
of IRadimed Corp?

Financials

Balance Sheet Decomposition
IRadimed Corp

Current Assets 71.9m
Cash & Short-Term Investments 46.8m
Receivables 12.8m
Other Current Assets 12.4m
Non-Current Assets 15.5m
PP&E 11m
Intangibles 2.5m
Other Non-Current Assets 2m
Current Liabilities 7.9m
Accounts Payable 2.8m
Accrued Liabilities 2.8m
Other Current Liabilities 2.3m
Non-Current Liabilities 5m
Other Non-Current Liabilities 5m
Efficiency

Earnings Waterfall
IRadimed Corp

Revenue
65.6m USD
Cost of Revenue
-15.4m USD
Gross Profit
50.2m USD
Operating Expenses
-30.1m USD
Operating Income
20m USD
Other Expenses
-2.8m USD
Net Income
17.2m USD

Free Cash Flow Analysis
IRadimed Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

IRMD Profitability Score
Profitability Due Diligence

IRadimed Corp's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Exceptional ROIC
Positive Free Cash Flow
76/100
Profitability
Score

IRadimed Corp's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

IRMD Solvency Score
Solvency Due Diligence

IRadimed Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

IRadimed Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IRMD Price Targets Summary
IRadimed Corp

Wall Street analysts forecast IRMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IRMD is 60.18 USD with a low forecast of 56.56 USD and a high forecast of 64.05 USD.

Lowest
Price Target
56.56 USD
40% Upside
Average
Price Target
60.18 USD
49% Upside
Highest
Price Target
64.05 USD
59% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

IRMD Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

IRMD Price
IRadimed Corp

1M 1M
-9%
6M 6M
+3%
1Y 1Y
-2%
3Y 3Y
+67%
5Y 5Y
+59%
10Y 10Y
+329%
Annual Price Range
40.36
52w Low
37.31
52w High
50.61
Price Metrics
Average Annual Return 14.06%
Standard Deviation of Annual Returns 66.5%
Max Drawdown -49%
Shares Statistics
Market Capitalization 508.5m USD
Shares Outstanding 12 739 100
Percentage of Shares Shorted 1.48%

IRMD Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

IRadimed Corp Logo
IRadimed Corp

Country

United States of America

Industry

Health Care

Market Cap

508.5m USD

Dividend Yield

0.37%

Description

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. The company is headquartered in Winter Springs, Florida and currently employs 110 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities, both in the United States and internationally.

Contact

FLORIDA
Winter Springs
1025 Willa Springs Dr
+14076778022.0
http://www.iradimed.com/

IPO

2014-07-16

Employees

110

Officers

Founder, Chairman, CEO & President
Mr. Roger E. Susi
CFO & Corporate Secretary
Mr. John F. Glenn
Vice President of Worldwide Sales & Marketing
Mr. Randy Waddell
Vice President of Regulatory Affairs & Quality Assurance
Mr. Steve Kachelmeyer
Vice President of Research & Development
Mr. Lynn Neuhardt
Executive Vice President of Continuous Improvement & Information Technology
Mr. Chris Williamson
Show More
Controller
Mr. Matt Garner
Show Less

See Also

Discover More
What is the Intrinsic Value of one IRMD stock?

The intrinsic value of one IRMD stock under the Base Case scenario is 28.32 USD.

Is IRMD stock undervalued or overvalued?

Compared to the current market price of 40.36 USD, IRadimed Corp is Overvalued by 30%.